Analyst Viewpoint
Increase in incidence and prevalence of specific infectious diseases and genetic disorders is driving the global digital PCR (dPCR) and quantitative PCR (qPCR) market. dPCR and qPCR offer precise nucleic acid quantification across diagnostics, research, and forensics. Technological advancements and recent product approvals are the other major factors driving market development. Furthermore, expansion of molecular biology applications in genomics and personalized medicine is expected to bolster the global digital PCR (dPCR) and quantitative PCR (qPCR) industry growth during the forecast period.
Technological advancements, including high-throughput systems and integrated software solutions, to increase efficiency and accuracy offer lucrative opportunities to market players. Companies are focusing on increasing investment in life sciences research and infectious disease diagnostics in order to increase digital PCR (dPCR) and quantitative PCR (qPCR) market revenue.
Digital PCR is a molecular biology technique used to quantify and analyze nucleic acids. It is a digital version of the polymerase chain reaction (PCR) that partitions a sample into thousands or millions of individual reactions. Each reaction occurs in its own micro-scale chamber, such as a droplet or well, allowing for precise quantification of nucleic acid targets.
Digital PCR is particularly useful for applications requiring high sensitivity, accuracy, and the detection of rare events, such as the analysis of rare mutations or copy number variations.
Quantitative PCR, also known as real-time PCR, is a widely used molecular biology technique for the amplification and quantification of DNA. Unlike traditional PCR, qPCR allows for the monitoring of the amplification process in real-time.
Fluorescent dyes or probes are used to detect the accumulating PCR product during each cycle, enabling the measurement of the starting amount of the target nucleic acid. Quantitative PCR is highly sensitive and provides relative quantification by comparing the amplification of the target to that of a reference or control sample. It is commonly employed for gene expression analysis, viral load quantification, and other applications requiring accurate quantification of nucleic acid levels.
The global digital PCR (dPCR) and quantitative PCR (qPCR) market for genomic analysis techniques has witnessed substantial growth, propelled by increase in incidence of infectious diseases and genetic disorders. Steady rise in demand for genomic analysis in the last decade has led to increase in application of techniques such as microbial identification and detection of genetic mutations.
These techniques play a pivotal role in diagnosing major infectious diseases, such as HIV, tuberculosis, malaria, hepatitis, and Staph-related diseases, as well as genetic disorders including cancer and fragile X syndrome.
According to the American Cancer Society, around 1.9 million new cancer cases are projected to be diagnosed in the U.S. in 2022, along with an estimated 609,360 cancer-related deaths. These statistics underscore the ongoing challenges posed by cancer and emphasize the need for comprehensive approaches to prevention, early detection, and effective treatment.
The proven efficacy of PCR analysis in diagnosing and estimating disease-causing microbes has further fueled the adoption of clinical diagnostic tests, including qPCR and dPCR analysis. Particularly noteworthy is the impact on regions, such as eastern and southern Africa, where the prevalence of HIV is significant. The advent of modern dPCR technologies has contributed to a substantial increase in awareness and early detection, exemplified by four in five cases of HIV patients being aware of their condition. This transformative impact underscores the vital role of advanced genomic analysis in driving digital PCR (dPCR) and quantitative PCR (qPCR) market growth.
Ongoing technological advancements and recent product approvals are driving digital PCR (dPCR) and quantitative PCR (qPCR) market demand. Continuous evolution of innovative technologies, coupled with regulatory approvals for new products, enhances the capabilities of dPCR and qPCR, meeting the growing needs of precise nucleic acid quantification across various applications.
In October 2022, Roche secured FDA clearance for its COVID-19 PCR test designed for use on cobas 6800/8800 systems. This automated, high-throughput cobas SARS-CoV-2 Qualitative test is among the first FDA-cleared PCR tests for COVID-19, reflecting advancements in automated testing.
This dynamic landscape highlights the digital PCR (dPCR) and quantitative PCR (qPCR) market's resilience and its ability to meet evolving requirements in diagnostics, research, and forensics. The combination of advanced features and regulatory milestones contributes to the persistent and robust demand for dPCR and qPCR solutions.
In terms of product type, the quantitative PCR segment accounted for the largest global digital PCR (dPCR) and quantitative PCR (qPCR) market share in 2022. The trend is expected to continue during the forecast period.
The diagnostic industry is undergoing a transformative phase, spurred by rapid technological advancements and surge in demand for automated systems and point-of-care diagnostics. This growth is exemplified by the swift integration of cutting-edge solutions such as real-time PCR for COVID-19 screening and diagnosis.
In February 2023, Huwel Lifesciences, a key player in this evolution, demonstrated its commitment by developing a portable RT-PCR system capable of testing various virus types. This innovation aligns with the industry's trajectory toward more efficient and versatile diagnostic tools.
Based on application, the clinical applications segment dominated the global digital PCR (dPCR) and quantitative PCR (qPCR) industry in 2022. The segment is driven by the evolving landscape of PCR influenced by the increasing demand in clinical settings. Rise in need for precise, reproducible, and reliable quantitative measurements of viral levels is another factor propelling the clinical applications segment.
Quantitative real-time PCR assumes a pivotal role in monitoring individuals with HIV and those undergoing antiretroviral therapy (ART). Monitoring is crucial to ensure the effective suppression of viral replication and the timely detection of any potential development of viral resistance to medication.
Demand for more sensitive assays for HIV has led to the innovation of diagnostic tests, continually pushing the boundaries of the limit of detection (LOD) and limit of quantification (LOQ) to lower thresholds. This persistent pursuit of heightened sensitivity emphasizes on the ongoing commitment to meet the evolving needs of clinical practice, enhancing the capabilities to manage and treat viral infections effectively.
In terms of end-user, the laboratories & academic institutes segment held significant share of the global digital PCR (dPCR) and quantitative PCR (qPCR) market in 2022.
Research laboratories & academic institutes are poised to play a substantial role in advancing the market. These institutions serve as hubs for innovation, continually pushing the boundaries of PCR technology.
In the dynamic landscape of research, demand for precise and advanced molecular diagnostic tools has driven the adoption of dPCR and qPCR methodologies. Versatility of these techniques in quantifying nucleic acids makes them invaluable in various academic disciplines and research domains.
Research laboratories, in particular, leverage dPCR and qPCR for applications ranging from gene expression studies to the detection of rare genetic mutations. Academic institutes, being at the forefront of scientific exploration, contribute to the development and refinement of these PCR technologies.
Continuous collaboration between academia and industry fosters advancements, leading to improved sensitivity, accuracy, and efficiency in nucleic acid analysis. As these institutions drive the evolution of PCR applications, their pivotal role is expected to expand, cementing their significance in shaping the trajectory of the dPCR and qPCR market.
As per digital PCR (dPCR) and quantitative PCR (qPCR) market forecast, the industry in North America is experiencing significant growth, driven by favorable regulations, government initiatives to develop healthcare infrastructure, and high disease prevalence in the region.
Presence of key manufacturers and increase in demand for rapid diagnostic tests are expected to contribute to digital PCR (dPCR) and quantitative PCR (qPCR) market expansion in the region during the forecast period. Major players, recognizing the potential in the region, are adopting strategies such as geographical expansion, partnerships, collaborations, and mergers & acquisitions.
According to digital PCR (dPCR) and quantitative PCR (qPCR) market analysis, the industry in Asia Pacific is experiencing significant growth, fueled by factors such as increase in awareness, rise in healthcare expenditure, and surge in emphasis on molecular diagnostics in the region.
The prevalence of infectious diseases, coupled with a large and diverse population, contributes to the demand for advanced diagnostic technologies. Government initiatives aimed at improving healthcare infrastructure and access to diagnostic services, such as dPCR products & services, also play a pivotal role in propelling the digital PCR (dPCR) and quantitative PCR (qPCR) market.
Asia Pacific has witnessed rise in research activities and collaborations, fostering innovation in PCR technologies. This has led to the development of more sensitive and accurate assays for various applications, including infectious disease monitoring and genetic testing.
The global digital PCR (dPCR) and quantitative PCR (qPCR) market is fragmented, with the presence of large number of players. Companies are adopting strategies such as investment in R&D and merger & collaborations in order to increase market share.
Bio Rad Laboratories, Thermo Fisher Scientific, Inc., Qiagen, F. Hoffmann La Roche Ltd, Abbott Laboratories, Agilent Technologies, BD, Danaher Corporation, Merck KGaA, and Takara Bio, Inc., are the prominent players in the global market.
The digital PCR (dPCR) and quantitative PCR (qPCR) report profiles key players based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent Peptide therapeutics market developments.
| Attribute | Detail |
|---|---|
| Size in 2022 | US$ 4.3 Bn |
| Forecast Value in 2031 | More than US$ 7.5 Bn |
| CAGR - 2022–2031 | 6.3% |
| Forecast Period | 2023-2031 |
| Historical Data Available for | 2017-2021 |
| Quantitative Units | US$ Mn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
It was valued at US$ 4.3 Bn in 2022
It is projected to reach more than US$ 7.5 Bn by 2031
It is anticipated to grow at a CAGR of 6.3% from 2023 to 2031
Increase in incidence and prevalence of specific infectious diseases & genetic disorders and technological advancements & recent product approvals.
North America is expected to account for largest share during the forecast period.
Bio Rad Laboratories, Thermo Fisher Scientific, Inc., Qiagen, F. Hoffmann La Roche Ltd., Abbott Laboratories, Agilent Technologies, BD, Danaher Corporation, Merck KGaA, and Takara Bio, Inc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast, 2023–2031
5. Key Insights
5.1. Applications of real-time PCR in the continuum of care and patient management.
5.2. Strengths of dPCR and qPCR
5.3. Key product/brand Analysis
5.4. Technological Advancements
5.5. Top 3 players operating in the market space
5.6. COVID Impact Analysis
6. Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product Type, 2023–2031
6.3.1. Quantitative PCR
6.3.1.1. Reagents & Consumables
6.3.1.2. Instruments
6.3.1.3. Software
6.3.2. Digital PCR
6.3.2.1. Reagents & Consumables
6.3.2.2. Instruments
6.3.2.3. Software
6.4. Market Attractiveness Analysis, by Product Type
7. Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2023–2031
7.3.1. Clinical Applications
7.3.2. Research Applications
7.3.3. Pathogen Testing
7.3.4. Oncology Testing
7.3.5. Blood Screening
7.3.6. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2023–2031
8.3.1. Hospitals & Diagnostic Centers
8.3.2. Research Laboratories & Academic Institutes
8.3.3. Pharmaceutical & Biotechnology Companies
8.3.4. Clinical Research Organizations
8.3.5. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2023–2031
10.2.1. Quantitative PCR
10.2.1.1. Reagents & Consumables
10.2.1.2. Instruments
10.2.1.3. Software
10.2.2. Digital PCR
10.2.2.1. Reagents & Consumables
10.2.2.2. Instruments
10.2.2.3. Software
10.3. Market Value Forecast, by Application, 2023–2031
10.3.1. Clinical Applications
10.3.2. Research Applications
10.3.3. Pathogen Testing
10.3.4. Oncology Testing
10.3.5. Blood Screening
10.3.6. Others
10.4. Market Value Forecast, by End-user, 2023–2031
10.4.1. Hospitals & Diagnostic Centers
10.4.2. Research Laboratories & Academic Institutes
10.4.3. Pharmaceutical & Biotechnology Companies
10.4.4. Clinical Research Organizations
10.4.5. Others
10.5. Market Value Forecast, by Country, 2023–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2023–2031
11.2.1. Quantitative PCR
11.2.1.1. Reagents & Consumables
11.2.1.2. Instruments
11.2.1.3. Software
11.2.2. Digital PCR
11.2.2.1. Reagents & Consumables
11.2.2.2. Instruments
11.2.2.3. Software
11.3. Market Value Forecast, by Application, 2023–2031
11.3.1. Clinical Applications
11.3.2. Research Applications
11.3.3. Pathogen Testing
11.3.4. Oncology Testing
11.3.5. Blood Screening
11.3.6. Others
11.4. Market Value Forecast, by End-user, 2023–2031
11.4.1. Hospitals & Diagnostic Centers
11.4.2. Research Laboratories & Academic Institutes
11.4.3. Pharmaceutical & Biotechnology Companies
11.4.4. Clinical Research Organizations
11.4.5. Others
11.5. Market Value Forecast, by Country/Sub-region, 2023–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2023–2031
12.2.1. Quantitative PCR
12.2.1.1. Reagents & Consumables
12.2.1.2. Instruments
12.2.1.3. Software
12.2.2. Digital PCR
12.2.2.1. Reagents & Consumables
12.2.2.2. Instruments
12.2.2.3. Software
12.3. Market Value Forecast, by Application, 2023–2031
12.3.1. Clinical Applications
12.3.2. Research Applications
12.3.3. Pathogen Testing
12.3.4. Oncology Testing
12.3.5. Blood Screening
12.3.6. Others
12.4. Market Value Forecast, by End-user, 2023–2031
12.4.1. Hospitals & Diagnostic Centers
12.4.2. Research Laboratories & Academic Institutes
12.4.3. Pharmaceutical & Biotechnology Companies
12.4.4. Clinical Research Organizations
12.4.5. Others
12.5. Market Value Forecast, by Country/Sub-region, 2023–2031
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2023–2031
13.2.1. Quantitative PCR
13.2.1.1. Reagents & Consumables
13.2.1.2. Instruments
13.2.1.3. Software
13.2.2. Digital PCR
13.2.2.1. Reagents & Consumables
13.2.2.2. Instruments
13.2.2.3. Software
13.3. Market Value Forecast, by Application, 2023–2031
13.3.1. Clinical Applications
13.3.2. Research Applications
13.3.3. Pathogen Testing
13.3.4. Oncology Testing
13.3.5. Blood Screening
13.3.6. Others
13.4. Market Value Forecast, by End-user, 2023–2031
13.4.1. Hospitals & Diagnostic Centers
13.4.2. Research Laboratories & Academic Institutes
13.4.3. Pharmaceutical & Biotechnology Companies
13.4.4. Clinical Research Organizations
13.4.5. Others
13.5. Market Value Forecast, by Country/Sub-region, 2023–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2023–2031
14.2.1. Quantitative PCR
14.2.1.1. Reagents & Consumables
14.2.1.2. Instruments
14.2.1.3. Software
14.2.2. Digital PCR
14.2.2.1. Reagents & Consumables
14.2.2.2. Instruments
14.2.2.3. Software
14.3. Market Value Forecast, by Application, 2023–2031
14.3.1. Clinical Applications
14.3.2. Research Applications
14.3.3. Pathogen Testing
14.3.4. Oncology Testing
14.3.5. Blood Screening
14.3.6. Others
14.4. Market Value Forecast, by End-user, 2023–2031
14.4.1. Hospitals & Diagnostic Centers
14.4.2. Research Laboratories & Academic Institutes
14.4.3. Pharmaceutical & Biotechnology Companies
14.4.4. Clinical Research Organizations
14.4.5. Others
14.5. Market Value Forecast, by Country/Sub-region, 2023–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company (2021)
15.3. Company Profiles
15.3.1. Bio Rad Laboratories
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. Thermo Fisher Scientific, Inc.
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Qiagen
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. F. Hoffmann La Roche Ltd.
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Abbott Laboratories
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Agilent Technologies
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. BD
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. Danaher Corporation
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview
15.3.9. Merck KGaA
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. Financial Overview
15.3.9.4. SWOT Analysis
15.3.9.5. Strategic Overview
15.3.10. Takara Bio, Inc.
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. Financial Overview
15.3.10.4. SWOT Analysis
15.3.10.5. Strategic Overview
List of Tables
Table 01: Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by Product Type, 2023–2031
Table 02: Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by Application, 2023–2031
Table 03: Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by End-user, 2023–2031
Table 04: Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by Region, 2023–2031
Table 05: North America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by Product Type, 2023–2031
Table 06: North America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by Application, 2023–2031
Table 07: North America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by End-user, 2023–2031
Table 08: North America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by Country, 2023–2031
Table 09: Europe Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by Product Type, 2023–2031
Table 10: Europe Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by Application, 2023–2031
Table 11: Europe Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by End-user, 2023–2031
Table 12: Europe Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023–2031
Table 13: Asia Pacific Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by Product Type, 2023–2031
Table 14: Asia Pacific Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by Application, 2023–2031
Table 15: Asia Pacific Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by End-user, 2023–2031
Table 16: Asia Pacific Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023–2031
Table 17: Latin America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by Product Type, 2023–2031
Table 18: Latin America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by Application, 2023–2031
Table 19: Latin America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by End-user, 2023–2031
Table 20: Latin America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023–2031
Table 21: Middle East & Africa Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by Product Type, 2023–2031
Table 22: Middle East & Africa Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by Application, 2023–2031
Table 23: Middle East & Africa Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by End-user, 2023–2031
Table 24: Middle East & Africa Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023–2031
List of Figures
Figure 1 : Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast 2023–2031
Figure 2 : Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value Share by Product Type 2022
Figure 3 : Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value Share by Application 2022
Figure 4 : Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value Share by End-user 2022
Figure 5 : Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value Share Analysis by Product Type 2022 and 2031
Figure 6 : Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Revenue (US$ Mn) by Quantitative PCR 2017–2031
Figure 7 : Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Revenue (US$ Mn) by Digital PCR 2017–2031
Figure 8 : Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Attractiveness Analysis, by Application 2023–2031
Figure 9 : Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value Share Analysis by Application 2022 and 2031
Figure 10: Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Revenue (US$ Mn) by Clinical Applications 2017–2031
Figure 11: Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Revenue (US$ Mn) by Pathogen Testing 2017–2031
Figure 12: Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Revenue (US$ Mn) by Oncology Testing 2017–2031
Figure 13: Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Revenue (US$ Mn) by Research Applications 2017–2031
Figure 14: Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Revenue (US$ Mn) by Blood Screening 2017–2031
Figure 15: Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Revenue (US$ Mn) by Others 2017–2031
Figure 16: Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Attractiveness Analysis, by End-user 2023–2031
Figure 17: Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value Share Analysis by End-user 2022 and 2031
Figure 18: Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Revenue (US$ Mn) by Hospitals & Diagnostic Centers 2017–2031
Figure 19: Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Revenue (US$ Mn) by Research Laboratories & Academic Institutes 2017–2031
Figure 20: Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Revenue (US$ Mn) by Pharmaceutical & Biotechnology Companies 2017–2032
Figure 21: Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Revenue (US$ Mn) by Clinical Research Organizations 2017–2032
Figure 22: Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Revenue (US$ Mn) by Others 2017–2032
Figure 23: Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value Share Analysis by Region 2022 and 2031
Figure 24: Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Attractiveness Analysis, by Region 2023–2031
Figure 25: North America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast 2017–2031
Figure 26: North America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value Share Analysis by Country 2022 and 2031
Figure 27: North America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Attractiveness Analysis, by Country 2023–2031
Figure 28: North America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value Share Analysis by Product Type 2022 and 2031
Figure 29: North America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Attractiveness Analysis, by Product Type 2023–2031
Figure 30: North America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value Share Analysis by Application 2022 and 2031
Figure 31: North America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Attractiveness Analysis, by Application 2023–2031
Figure 32: North America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value Share Analysis by End-user 2022 and 2031
Figure 33: North America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Attractiveness Analysis, by End-user 2023–2031
Figure 34: Europe Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast 2023–2031
Figure 35: Europe Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value Share Analysis by Country/Sub-region, 2022 and 2031
Figure 36: Europe Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 37: Europe Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value Share Analysis by Product Type 2022 and 2031
Figure 38: Europe Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Attractiveness Analysis, by Product Type 2023–2031
Figure 39: Europe Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value Share Analysis by Application 2022 and 2031
Figure 40: Europe Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Attractiveness Analysis, by Application 2023–2031
Figure 41: Europe Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value Share Analysis by End-user 2022 and 2031
Figure 42: Europe Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Attractiveness Analysis, by End-user 2023–2031
Figure 43: Asia Pacific Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast 2023–2031
Figure 44: Asia Pacific Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value Share Analysis by Country/Sub-region, 2022 and 2031
Figure 45: Asia Pacific Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 46: Asia Pacific Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value Share Analysis by Product Type 2022 and 2031
Figure 47: Asia Pacific Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Attractiveness Analysis, by Product Type 2023–2031
Figure 48: Asia Pacific Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value Share Analysis by Application 2022 and 2031
Figure 49: Asia Pacific Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Attractiveness Analysis, by Application 2023–2031
Figure 50: Asia Pacific Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value Share Analysis by End-user 2022 and 2031
Figure 51: Asia Pacific Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Attractiveness Analysis, by End-user 2023–2031
Figure 52: Latin America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast 2023–2031
Figure 53: Latin America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value Share Analysis by Country/Sub-region, 2022 and 2031
Figure 54: Latin America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 55: Latin America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value Share Analysis by Product Type 2022 and 2031
Figure 56: Latin America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Attractiveness Analysis, by Product Type 2023–2031
Figure 57: Latin America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value Share Analysis by Application 2022 and 2031
Figure 58: Latin America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Attractiveness Analysis, by Application 2023–2031
Figure 59: Latin America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value Share Analysis by End-user 2022 and 2031
Figure 60: Latin America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Attractiveness Analysis, by End-user 2023–2031
Figure 61: Middle East & Africa Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) 2017–2031
Figure 62: Middle East & Africa Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value Share Analysis by Country/Sub-region 2022 and 2031
Figure 63: Middle East & Africa Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Attractiveness by Country/Sub-region 2023–2031
Figure 64: Middle East & Africa Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value Share Analysis by Product Type 2022 and 2031
Figure 65: Middle East & Africa Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Attractiveness by Product Type 2023–2031
Figure 66: Middle East & Africa Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value Share Analysis by Application 2022 and 2031
Figure 67: Middle East & Africa Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Attractiveness by Application 2023–2031
Figure 68: Middle East & Africa Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value Share Analysis by End-user 2022 and 2031
Figure 69: Middle East & Africa Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Attractiveness by End-user 2023–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Digital PCR (dPCR) and Quantitative PCR (qPCR) Market
